Company intelligence / Profile preview
Inmunotek
- Ownership
- Private
- Employees
- ~332
- Development stage
- Phase 3
Overview
Inmunotek develops, manufactures, and markets diagnostic and therapeutic products for allergy and immunology. Its products are approved by the Spanish Drug Agency and several international agencies. The company has received multiple awards for innovation and business growth. It operates globally with a broad product portfolio focused on allergy immunotherapy, infectious disease vaccines, cancer vaccines, diagnostics, and medical devices. Specific clinical trial results are not detailed in public sources.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Therapeutic vaccines (allergy, infectious diseases, cancer)ImmunotherapyMedical devices
- Industry
- Biotech
Drug pipeline
50 assets49 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Inmunotek.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inmunotek.